Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Peginterferon α-2b for Pediatric RSV Pneumonia
NCT06881056Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised, open-label trial of peginterferon alfa-2b in respiratory syncytial virus pneumonia (3 arms), sponsored by West China Second University Hospital. Primary endpoints: Time for the disappearance of major clinical symptoms at Day 6 and Time of disappearance of abnormal signs at Day 6. Started Jul 2024; status: recruiting.
02
Drugs
peginterferon alfa-2b
03
Conditions
respiratory syncytial virus pneumonia
Beyond the preview
Go deeper on NCT06881056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06881056.